Managing Director
Managing Director

Dr. Ali Akbar Pourfathollah has been the Managing Director of IBTO since 2013. He had served IBTO with the same position from 1999 to 2005. Dr. Pourfathollah is a recognized expert in Immunology and Hematology with more than 100 scientific publications. He acquired his PhD degree in immunology from Tarbiat Modares University in 1993 and has been the faculty member of the same university since 1995. In 2005, he was appointed as the professor of Immunology. Along with his academic career, Dr. Pourfathollah has involved in several administrative positions including:

  • Advisor of Minister of Health and Medical Education: 1997 – 2000
  • Head of Hematology and Blood Banking Department, School of Medical Science, Tarbiat Modares University: 1994-2006
  • Head of Immunology Department, School of Medical Science, Tarbiat Modares University: 2008
  • Member of High Council of Iranian Blood Transfusion Organization: 2013-Now
  • President of High Institute of Research and Education on Transfusion Medicine: 2013-Now
  • President of Technical Council of Iranian Blood Transfusion Organization: 2013-Now
  • Member of "Hematology and Cancer Committee” of National Institute of Research Development of Medical Science: 2015-Now
  • Vice President of "Iranian National Network of Hematopoietic Stem cells Registry Centers and Cord Blood Banks":  2015-Now
  • Member of "Health Planning and Life Quality Promotion Council" Ministry of Health: 2015-Now

To know more about him, please click here .

More Information about articles...

The President Message of IBTO
The President Message of Iranian Blood Transfusion Organization (IBTO)
Today blood, blood components and plasma derived medicines are vital parts of the modern medicine and health care systems. Without blood and its components, saving lives of a large number of patients such as mothers and children would be impossible.
Transfusion Medicine has a long history in Iran. Since four decades ago and after the establishment of Iranian Blood Transfusion Organization (IBTO), all related activities including collection, quality control, surveillance and distribution of blood have been centralized and supervised by Ministry of Health (MOH).
During past four decades, IBTO has achieved remarkable successes that the greatest one, in recent years, was recording 100% voluntary non-remunerated blood donation in 2007.
Cultural and religious beliefs of Iranians not only led IBTO to the above goal and index of 27 donations per 1000 population, but also ranked Iran as pioneer nation in Eastern Mediterranean Region (EMR).
Collecting more than 2.1 million units of blood in 2015, applying an integrated quality assurance system and use of latest technologies in producing blood and blood products brought up IBTO as one of the prominent organization in Asia.
Through a suitable allocation of resources, Iranian health system has enabled IBTO to provide all patients with nationwide gratis products; hence, all patients are under umbrella of the service.
Due to risks related to blood transfusion and because the supply of blood and blood products is limited and costly, physicians should optimize blood usage and consider other alternatives to blood transfusion. We can reduce the need for blood transfusion by applying appropriate patient blood management, using autologous blood transfusion and trying to promote bloodless surgeries.
Since 2005, Iranian health system initiated a project to meet all Iranian needs for plasma-derived medicines based on donated plasma by Iranian donors; Although, the long term purpose of the program is to establish a national plasma fractionation center, main part of the needs of pharmaceutical market has been met by fractionation contracts with European partners. Regular audits by well-known international institutes are another verification fact to guarantee the quality of the products. Today, we are now able to produce 200,000 liters recovered and 200,000 liters source plasma.
I am extremely pleased to have had the opportunity to be a member of the huge family of IBTO.